CAPRLawsuitsprnewswire

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Sentiment:Negative (-40)

Summary

(NASDAQ:CAPR) LOS ANGELES, Sept. 2, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Capricor Therapeutics, Inc. ("Capricor" or "the Company") (NASDAQ: CAPR) for violations of §§10(b) and 20(a) of the Securities...

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on September 2, 2025 by prnewswire